139 related articles for article (PubMed ID: 19048427)
21. Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies.
Roth S; Abernathy MP; Lee WH; Pratt L; Denne S; Golichowski A; Pescovitz OH
J Soc Gynecol Investig; 1996; 3(2):78-84. PubMed ID: 8796812
[TBL] [Abstract][Full Text] [Related]
22. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy.
Suwaki N; Masuyama H; Masumoto A; Takamoto N; Hiramatsu Y
Placenta; 2007 Apr; 28(4):315-23. PubMed ID: 16753211
[TBL] [Abstract][Full Text] [Related]
23. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction.
Bahtiyar MO; Buhimschi C; Ravishankar V; Copel J; Norwitz E; Julien S; Guller S; Buhimschi IA
Am J Obstet Gynecol; 2007 Jan; 196(1):72.e1-6. PubMed ID: 17240241
[TBL] [Abstract][Full Text] [Related]
24. The relationship between transplacental O2 diffusion and placental expression of PlGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction.
Regnault TR; de Vrijer B; Galan HL; Davidsen ML; Trembler KA; Battaglia FC; Wilkening RB; Anthony RV
J Physiol; 2003 Jul; 550(Pt 2):641-56. PubMed ID: 12740423
[TBL] [Abstract][Full Text] [Related]
25. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.
Kumazaki K; Nakayama M; Suehara N; Wada Y
Hum Pathol; 2002 Nov; 33(11):1069-77. PubMed ID: 12454810
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
[TBL] [Abstract][Full Text] [Related]
27. Placental glycogen metabolism in diabetic pregnancy.
Shafrir E; Barash V
Isr J Med Sci; 1991; 27(8-9):449-61. PubMed ID: 1835720
[TBL] [Abstract][Full Text] [Related]
28. Taurine attenuates maternal and embryonic oxidative stress in a streptozotocin-diabetic rat model.
Shivananjappa MM; Muralidhara
Reprod Biomed Online; 2012 May; 24(5):558-66. PubMed ID: 22414371
[TBL] [Abstract][Full Text] [Related]
29. Expression of placenta growth factor mRNA in the rat placenta during mid-late pregnancy.
Choi WS; Cho GJ; Won CK; Koh PO
J Vet Sci; 2005 Sep; 6(3):179-83. PubMed ID: 16131818
[TBL] [Abstract][Full Text] [Related]
30. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats.
Sivan E; Lee YC; Wu YK; Reece EA
Teratology; 1997 Dec; 56(6):343-9. PubMed ID: 9485543
[TBL] [Abstract][Full Text] [Related]
31. Effects of Lipoic Acid Supplementation on Activities of Cyclooxygenases and Levels of Prostaglandins E
Al-Matubsi HY; Oriquat GA; Abu-Samak M; Al Hanbali OA; Salim MD
J Diabetes Res; 2016; 2016():9354937. PubMed ID: 28042582
[No Abstract] [Full Text] [Related]
32. Rapamycin administration during normal and diabetic pregnancy effects the mTOR and angiogenesis signaling in the rat placenta.
Ozmen A; Kipmen-Korgun D; Korgun ET
J Gynecol Obstet Hum Reprod; 2019 Mar; 48(3):193-199. PubMed ID: 30553049
[TBL] [Abstract][Full Text] [Related]
33. Dietary treatments enriched in olive and safflower oils regulate seric and placental matrix metalloproteinases in maternal diabetes.
Martinez N; Sosa M; Higa R; Fornes D; Capobianco E; Jawerbaum A
Placenta; 2012 Jan; 33(1):8-16. PubMed ID: 22098918
[TBL] [Abstract][Full Text] [Related]
34. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.
Cianfarani F; Zambruno G; Brogelli L; Sera F; Lacal PM; Pesce M; Capogrossi MC; Failla CM; Napolitano M; Odorisio T
Am J Pathol; 2006 Oct; 169(4):1167-82. PubMed ID: 17003476
[TBL] [Abstract][Full Text] [Related]
35. Maternal diabetes affects cell proliferation in developing rat placenta.
Zorn TM; Zúñiga M; Madrid E; Tostes R; Fortes Z; Giachini F; San Martín S
Histol Histopathol; 2011 Aug; 26(8):1049-56. PubMed ID: 21692037
[TBL] [Abstract][Full Text] [Related]
36. PPARα agonists regulate lipid metabolism and nitric oxide production and prevent placental overgrowth in term placentas from diabetic rats.
Martínez N; Kurtz M; Capobianco E; Higa R; White V; Jawerbaum A
J Mol Endocrinol; 2011 Aug; 47(1):1-12. PubMed ID: 21502283
[TBL] [Abstract][Full Text] [Related]
37. Folic acid supplementation affects ROS scavenging enzymes, enhances Vegf-A, and diminishes apoptotic state in yolk sacs of embryos of diabetic rats.
Zabihi S; Eriksson UJ; Wentzel P
Reprod Toxicol; 2007 Jun; 23(4):486-98. PubMed ID: 17482424
[TBL] [Abstract][Full Text] [Related]
38. Altered uterine perfusion is involved in fetal outcome of diabetic rats.
Zabihi S; Wentzel P; Eriksson UJ
Placenta; 2008 May; 29(5):413-21. PubMed ID: 18387670
[TBL] [Abstract][Full Text] [Related]
39. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy.
Ornoy A
Reprod Toxicol; 2007 Jul; 24(1):31-41. PubMed ID: 17548185
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women.
Pietro L; Daher S; Rudge MV; Calderon IM; Damasceno DC; Sinzato YK; Bandeira C; Bevilacqua E
Placenta; 2010 Sep; 31(9):770-80. PubMed ID: 20674013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
